| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; human; 1:400; fig 1c
| Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti E, et al. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9:2643 pubmed publisher |
- immunohistochemistry - paraffin section; mouse; loading ...; fig s2b
| Zhu F, Zhu Q, Ye D, Zhang Q, Yang Y, Guo X, et al. Sin3a-Tet1 interaction activates gene transcription and is required for embryonic stem cell pluripotency. Nucleic Acids Res. 2018;46:6026-6040 pubmed publisher |
- immunocytochemistry; human; 1:400; loading ...; fig 1j
| Jansch C, Günther K, Waider J, Ziegler G, Forero A, Kollert S, et al. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3. Stem Cell Res. 2018;28:136-140 pubmed publisher |
- immunocytochemistry; human; 1:400; fig 1j
| Alonso Barroso E, Brasil S, Briso Montiano Á, Navarrete R, Perez Cerda C, Ugarte M, et al. Generation and characterization of a human iPSC line from a patient with propionic acidemia due to defects in the PCCA gene. Stem Cell Res. 2017;23:173-177 pubmed publisher |
- immunocytochemistry; human; 1:500; loading ...; tbl s4
| Hansen S, Stummann T, Borland H, Hasholt L, Tumer Z, Nielsen J, et al. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3. Stem Cell Res. 2016;17:306-317 pubmed publisher |
- immunocytochemistry; human; 1:500; loading ...; tbl 2
| Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11. Stem Cell Res. 2016;16:589-92 pubmed publisher |
- immunocytochemistry; human; 1:500; fig 1e
| Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11. Stem Cell Res. 2016;16:553-6 pubmed publisher |
- immunohistochemistry; human; 1:500; loading ...; fig s9d
| Hyslop L, Blakeley P, Craven L, Richardson J, Fogarty N, Fragouli E, et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature. 2016;534:383-6 pubmed publisher |
- immunohistochemistry; human; fig s3
| Leung C, Mak W, Kai A, Chan K, Lee T, Ng I, et al. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/?-catenin signaling. Oncotarget. 2016;7:29371-86 pubmed publisher |
- immunocytochemistry; human; 1:500
| Sagi I, Chia G, Golan Lev T, Peretz M, Weissbein U, Sui L, et al. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016;532:107-11 pubmed publisher |
- immunocytochemistry; human; 1:400; fig 2
| Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher |
- western blot; human; fig 1
| Castaño J, Morera C, Sesé B, Boue S, Bonet Costa C, Marti M, et al. SETD7 Regulates the Differentiation of Human Embryonic Stem Cells. PLoS ONE. 2016;11:e0149502 pubmed publisher |
- immunocytochemistry; human; 1:300; fig 1
| Malan D, Zhang M, Stallmeyer B, Müller J, Fleischmann B, Schulze Bahr E, et al. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Res Cardiol. 2016;111:14 pubmed publisher |
- immunocytochemistry; human; fig s1
| Kyttälä A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy K, et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports. 2016;6:200-12 pubmed publisher |
- western blot; human; 1:500; fig 4
| Geng Y, Feng B. Mesendogen, a novel inhibitor of TRPM6, promotes mesoderm and definitive endoderm differentiation of human embryonic stem cells through alteration of magnesium homeostasis. Heliyon. 2015;1:e00046 pubmed |
- immunocytochemistry; human; 1:4000; fig 6
| Holtzinger A, Streeter P, Sarangi F, Hillborn S, Niapour M, Ogawa S, et al. New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development. 2015;142:4253-65 pubmed publisher |
- immunocytochemistry; white-tufted-ear marmoset; 1:200; fig 3
| Debowski K, Warthemann R, Lentes J, Salinas Riester G, Dressel R, Langenstroth D, et al. Non-viral generation of marmoset monkey iPS cells by a six-factor-in-one-vector approach. PLoS ONE. 2015;10:e0118424 pubmed publisher |
- immunohistochemistry - paraffin section; mouse
| Karaca G, Xie G, Moylan C, Swiderska Syn M, Guy C, Krüger L, et al. Role of Fn14 in acute alcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2015;308:G325-34 pubmed publisher |
- immunocytochemistry; human; 1:100
| Gieseck R, Hannan N, Bort R, Hanley N, Drake R, Cameron G, et al. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS ONE. 2014;9:e86372 pubmed publisher |
- immunohistochemistry - paraffin section; mouse; 1:400; fig 7
- western blot; mouse; fig 7
| Karaca G, Swiderska Syn M, Xie G, Syn W, Krüger L, Machado M, et al. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS ONE. 2014;9:e83987 pubmed publisher |
| Tobias I, Brooks C, Teichroeb J, Betts D. Derivation and culture of canine embryonic stem cells. Methods Mol Biol. 2013;1074:69-83 pubmed publisher |
- immunocytochemistry; human
| Barrero M, Sesé B, Marti M, Izpisua Belmonte J. Macro histone variants are critical for the differentiation of human pluripotent cells. J Biol Chem. 2013;288:16110-6 pubmed publisher |
| Docta R, Ferronha T, Sanderson J, Weissensteiner T, Pope G, Bennett A, et al. Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver Cancer. Hepatology. 2019;69:2061-2075 pubmed publisher |
| Balboa D, Saarimäki Vire J, Borshagovski D, Survila M, Lindholm P, Galli E, et al. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. elife. 2018;7: pubmed publisher |
| Pars S, Cristo F, Inácio J, Rosas G, Carreira I, Melo J, et al. Generation and characterization of a human iPS cell line from a patient-related control to study disease mechanisms associated with DAND5 p.R152H alteration. Stem Cell Res. 2018;29:202-206 pubmed publisher |
| Veerman C, Mengarelli I, Lodder E, Kosmidis G, Bellin M, Zhang M, et al. Switch From Fetal to Adult SCN5A Isoform in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease-Causing Mutation. J Am Heart Assoc. 2017;6: pubmed publisher |
| Yoshizawa J, Ishizone S, Ikeyama M, Nakayama J. Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. BMC Cancer. 2017;17:368 pubmed publisher |
| Rikhi R, Wilson E, Déas O, Svalina M, Bial J, Mansoor A, et al. Murine model of hepatic breast cancer. Biochem Biophys Rep. 2016;8:1-5 pubmed publisher |
| Helal T, Radwan N, Shaker M. Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience. Diagn Pathol. 2015;10:82 pubmed publisher |
| Iwashita H, Shiraki N, Sakano D, Ikegami T, Shiga M, Kume K, et al. Secreted cerberus1 as a marker for quantification of definitive endoderm differentiation of the pluripotent stem cells. PLoS ONE. 2013;8:e64291 pubmed publisher |
